News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,141 Results
Type
Article (2576)
Company Profile (45)
Press Release (37519)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14192)
Career Advice (78)
Deals (2108)
Drug Delivery (9)
Drug Development (4144)
Employer Resources (10)
FDA (443)
Job Trends (782)
News (20272)
Policy (1057)
Tag
Academia (144)
Allergies (7)
Alliances (3491)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (31)
Autoimmune disease (9)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (327)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (33)
CDC (1)
Cell therapy (84)
Cervical cancer (2)
Clinical research (3442)
Collaboration (202)
Company closure (2)
Compensation (105)
COVID-19 (185)
CRISPR (11)
C-suite (114)
Cystic fibrosis (7)
Data (424)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (492)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (44)
Earnings (4516)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6415)
Executive appointments (135)
FDA (590)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (57)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (708)
HIV (2)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (5)
Infectious disease (198)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (26)
Interviews (7)
IPO (1002)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (315)
Medtech (316)
Mergers & acquisitions (1224)
Metabolic disorders (72)
Multiple sclerosis (23)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (166)
NextGen: Class of 2026 (353)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (18)
Pain (25)
Pancreatic cancer (22)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (28)
Peanut (1)
People (5879)
Pharmaceutical (5)
Phase 1 (1477)
Phase 2 (1704)
Phase 3 (916)
Pipeline (407)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (15)
Rare diseases (63)
Real estate (425)
Recruiting (5)
Regulatory (920)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (54)
Last 30 days (154)
Last 365 days (2434)
2026 (264)
2025 (2438)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1948)
Australia (307)
California (1615)
Canada (249)
China (81)
Colorado (55)
Connecticut (16)
Delaware (5)
Europe (4021)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (3)
Indiana (61)
Japan (18)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (576)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (137)
New York (81)
North Carolina (133)
Northern California (790)
Ohio (45)
Oklahoma (2)
Oregon (6)
Pennsylvania (113)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (1)
Southern California (657)
Tennessee (5)
Texas (153)
United States (3241)
Utah (5)
Virginia (12)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,141 Results for "xenetic biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
December 12, 2025
·
7 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
November 14, 2025
·
8 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
November 20, 2025
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
October 13, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
August 14, 2025
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
July 24, 2025
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
July 31, 2025
·
7 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
Press Releases
Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
6 min read
1 of 4,015
Next
